Philippe Garot, Marie-Claude Morice, Dominick J Angiolillo, Josep Rodés- Cabau, Duk-Woo Park, Nicolas M Van Mieghem, Jean-Philippe Collet, Martin B Leon, Gunasekaran Sengottuvelu, Antoinette Neylon, Jurrien M Ten Berg, Darren Mylotte, Didier Tchétché, Mitchell W Krucoff, Michael J Reardon, Nicolo Piazza, Michael J Mack, Philippe Généreux, Raj Makkar, Kentaro Hayashida, Yohei Ohno, Shuichi Mochizuki, Yuko Shirai, Ryosuke Matsumara, Yu Jin, John G Webb, Donald E Cutlip, Mao Chen, Ernest Spitzer, Roxana Mehran, Davide Capodanno
<span style="font-size:12pt"><span style="font-family:Aptos,sans-serif">The identification and management of patients at high bleeding risk (HBR) undergoing transcatheter aortic valve implantation (TAVI) are of major importance, but the lack of standardised definitions is challenging for trial design, data interpretation, and clinical decision-making. The Valve Academic Research Consortium for High Bleeding Risk (VARC-HBR) is a collaboration among leading research organisations, regulatory authorities, and physician-scientists from Europe, the USA, and Asia, with a major focus on TAVI-related bleeding...
May 10, 2024: EuroIntervention